Evidence map›Paper›PMID 31060041›Full record

ArticleNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2019

Inhibition of the rostromedial tegmental nucleus reverses alcohol withdrawal-induced anxiety-like behavior.

Elizabeth J Glover, E Margaret Starr, Ying Chao, Thomas C Jhou, L Judson Chandler

Open access · bronzeAbstract read
In one paragraph

Article in Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Rostromedial tegmental nucleus nociceptin/orphanin FQ (N/OFQ) signaling regulates anxiety- and depression-like behaviors in alcohol withdrawn rats.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2023
    Article
  19. The lateral habenula is not required for ethanol dependence-induced escalation of drinking.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2022
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Elizabeth J GloverDepartment of Neuroscience, Medical University of South Carolina, Charleston, SC, 29425, USA. ejglover@uic.edu.ORCID http://orcid.org/0000-0001-5037-7576
E Margaret StarrDepartment of Neuroscience, Medical University of South Carolina, Charleston, SC, 29425, USA.
Ying ChaoDepartment of Neuroscience, Medical University of South Carolina, Charleston, SC, 29425, USA.
Thomas C JhouDepartment of Neuroscience, Medical University of South Carolina, Charleston, SC, 29425, USA.
L Judson ChandlerDepartment of Neuroscience, Medical University of South Carolina, Charleston, SC, 29425, USA.
Medical University of South Carolina · US

Funding

TREATING ETHANOL WITHDRAWAL WITH LORAZEPAM/NALTREXONEP50AA010761 · NIAAA · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI HOWARD C. BECKER · 1996 to 2026
$46.8M
Impact of Adolescent Alcohol Exposure on Prefrontal Cortical Function in the AdulU01AA019967 · NIAAA · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI CHANDLER, L JUDSON · 2010 to 2024
$5.3M
ETHANOL AND NITRIC OXIDE FORMATION IN BRAINR01AA010983 · NIAAA · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI CHANDLER, L JUDSON · 2001 to 2013
$3.5M
Adolescent Alcohol Abuse, Traumatic Stress, and Vulnerability to Development of PTSDR01AA027706 · NIAAA · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI CHANDLER, L JUDSON · 2020 to 2024
$2.7M
Neurobiological mechanisms underlying chronic tolerance to the aversive properties of ethanolR01AA029130 · NIAAA · UNIVERSITY OF ILLINOIS AT CHICAGO · PI GLOVER, ELIZABETH J · 2021 to 2025
$2.0M
Chronic Intermittent Ethanol and Kv4.2 ChannelsR01AA022701 · NIAAA · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI CHANDLER, L JUDSON · 2015 to 2019
$1.7M
Cocaine-Conditioned Avoidance Behavior, Mechanisms and Relevance for Drug-SeekingR01DA037327 · NIDA · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI JHOU, THOMAS C · 2014 to 2018
$1.7M
Diversity Supplement: Chronic alcohol and the neurocircuitry of aversionR00AA024208 · NIAAA · UNIVERSITY OF ILLINOIS AT CHICAGO · PI GLOVER, ELIZABETH J · 2018 to 2020
$803k
Chronic Alcohol and the Neurocircuitry of AversionK99AA024208 · NIAAA · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI GLOVER, ELIZABETH J · 2016 to 2017
$268k
NIAAA NIH HHS K99 AA024208NIAAA NIH HHS P50 AA010761NIAAA NIH HHS R00 AA024208NIAAA NIH HHS R01 AA010983NIAAA NIH HHS R01 AA022701NIAAA NIH HHS R01 AA027706NIAAA NIH HHS R01 AA029130NIAAA NIH HHS U01 AA019967NIDA NIH HHS R01 DA037327
6 · The paper itself

Abstract

Acute withdrawal from alcohol is associated with a number of unpleasant symptoms that play an important role in preventing recovery and long-term abstinence. Considerable research has focused on the role that neuropeptide systems and the amygdala play in mediating affective symptoms of acute withdrawal, but promising preclinical findings have not translated successfully into the clinic. The rostromedial tegmental nucleus (RMTg) has been implicated in both fear and anxiety. In addition, RMTg neurons exert inhibitory control over midbrain dopamine neurons, the activity of which are suppressed during acute withdrawal. Thus, we hypothesized that the RMTg may play a role in mediating symptoms of acute withdrawal. Using a chronic ethanol vapor exposure paradigm that renders rats physically dependent on ethanol, we observed significant withdrawal-induced enhancement of cFos expression in the RMTg. This was accompanied by a significant increase in somatic symptoms and a decrease in reward sensitivity as measured by intracranial self-stimulation (ICSS). Both measures followed a similar time course to RMTg cFos expression with peak symptom severity occurring 12 h following cessation of ethanol exposure. Heightened anxiety-like behavior was also observed in withdrawn rats at this same time point. RMTg inhibition had no effect on somatic signs of withdrawal or withdrawal-induced changes in reward sensitivity, but significantly attenuated withdrawal-induced anxiety-like behavior. Together, these data demonstrate that the RMTg plays a distinct role in the negative affective state associated with acute withdrawal and may therefore be critically involved in the neurobiological mechanisms that promote relapse during early stages of recovery.

Indexed as

Action PotentialsAnimalsAnxietyBehavior, AnimalEthanolGABA-A Receptor AgonistsMaleMuscimolNeuronsProto-Oncogene Proteins c-fosRatsRats, Long-EvansSelf StimulationSubstance Withdrawal SyndromeVentral Tegmental AreaEthanolGABA-A Receptor AgonistsMuscimolProto-Oncogene Proteins c-fos

Identifiers

PMID31060041
PMCPMC6785010
OpenAlexW2942700700

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.